Bifonazole/Triamcinolone Acetonide

联苯苄唑/曲安奈德

Report date: 2025/11/14 14:16:48

Base Information

Drug NameBifonazole/Triamcinolone Acetonide
Drug Alias NameN/A
ClassificationSmall molecules > Steroids
Mechanisms of ActionLanosterol 14α-demethylase inhibitorsGlucocorticoid receptor agonists
TargetsLanosterol 14α-demethylaseGlucocorticoid receptor
Therapy Area/IndicationsVulvovaginitisTinea VersicolorTinea Pedis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes BifonazoleTriamcinolone Acetonide
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesLiaoning Dasheng Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLiaoning Dasheng Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsVulvovaginitisTinea VersicolorTinea Pedis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A